Green Thumb Industries (OTCMKTS:GTBIF) Posts Earnings Results, Beats Expectations By $0.03 EPS

Green Thumb Industries (OTCMKTS:GTBIF) issued its quarterly earnings data on Monday. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.06 by $0.03, Zacks reports. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%. The business had revenue of $280.15 million for the quarter, compared to the consensus estimate of $277.01 million.

Green Thumb Industries Trading Down 6.8 %

OTCMKTS:GTBIF traded down $0.74 on Tuesday, hitting $10.07. The company had a trading volume of 724,883 shares, compared to its average volume of 510,888. Green Thumb Industries has a 52 week low of $6.42 and a 52 week high of $16.33. The stock has a market capitalization of $2.14 billion, a price-to-earnings ratio of 41.96 and a beta of 1.41. The firm has a 50 day moving average of $11.61 and a two-hundred day moving average of $12.57.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on GTBIF shares. Needham & Company LLC lifted their target price on Green Thumb Industries from $15.50 to $17.00 and gave the company a “buy” rating in a research report on Thursday, May 9th. Wedbush upped their target price on Green Thumb Industries from $15.00 to $16.00 and gave the stock an “outperform” rating in a report on Friday, May 10th.

About Green Thumb Industries

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.